Medicare coverage does not necessarily mean appropriate reimbursement levels, a point pressed by Inspire Medical Systems Inc. at the Aug. 23 Medicare outpatient advisory panel hearing. The panel ...

Around 22 million Americans have sleep apnea. Traditional continuous positive airway pressure, or CPAP, machines are the standard treatment. However, they can be loud, uncomfortable and have a pesky ...

The FDA has labeled a recall of Inspire Medical Systems, Inc.’s (NYSE:INSP) nerve-stimulating implant for obstructive sleep apnea as Class I, the most serious kind. Inspire initiated a recall of its ...

The FDA recently cleared the Inspire therapy device, which can be used in a subset of patients with moderate to severe obstructive sleep apnea (OSA) who are unable to use continuous positive airway ...

Targeted hypoglossal nerve stimulation (THN) showed safety and efficacy for patients with moderate-to-severe obstructive sleep apnea (OSA), the randomized THN3 trial found. Four months after receiving ...

While Obstructive Sleep Apnea (OSA) affects about five percent of the general pediatric population, 80 percent of children with Down syndrome experience OSA. Continual OSA results in poor health, ...

Minnesota-based Inspire Medical Systems is voluntarily recalling a model of its Inspire IV Implantable Pulse Generator because of a manufacturing defect, the FDA said July 8. After implantation, the ...

A nerve-stimulation treatment for obstructive sleep apnea that originally was approved only for people with body mass indexes (BMIs) in the healthy range recently was extended to patients with BMIs up ...

A nerve-stimulation treatment for obstructive sleep apnea that originally was approved only for people with body mass indexes (BMIs) in the healthy range recently was extended to patients with BMIs up ...

Medicare coverage does not necessarily mean appropriate reimbursement levels, a point pressed by Inspire Medical Systems Inc. at the Aug. 23 Medicare outpatient advisory panel hearing. The panel ...